The themes Basel Medical is part of, the highest-graded companies in its industry, and the companies in its sector whose grade rose recently.
Graded A or B and worth $2B or more: A first, then the largest.
Rose to A or B on a filing in the last 90 days, worth $2B or more: largest first.
Built from Basel Medical Group Ltd’s own filings with the U.S. Securities and Exchange Commission (SEC). Figures are as reported, with per-share history restated onto today’s share basis. This company files in SGD. Figures are converted to US dollars at $1.00 = 1.2881 SGD, the current rate, applied to every period alike — so growth and margins are the company’s own and not the exchange rate’s. This describes a business — it is not investment advice and not a recommendation to buy or sell anything.
$0.48-13.5%Nov 13 close
Figures through June 30, 2025, from the 20-F/A filed March 13, 2026
Not rated
The band under the price shows the grade on each date, built only from filings that were public by then.
There is no grade history to chart for Basel Medical Group Ltd yet. The quarterly grade is rebuilt from only the filings that were public at the time, and this company has not yet reported enough of them to score a single quarter.